Needham Maintains Buy on Kornit Digital, Lowers Price Target to $38
Needham analyst James Ricchiuti maintains Kornit Digital (NASDAQ:KRNT) with a Buy and lowers the price target from $75 to $38.
U.S. Stock Futures Edge Lower; FOMC Meeting Minutes In Focus
Pre-open movers
U.S. stock futures traded slightly lower in early pre-market trade on Tuesday ahead of the release of minutes from the latest Fed meeting.
Goldman Sachs Maintains Neutral on APA, Lowers Price Target to $41
Goldman Sachs maintains APA (NASDAQ:APA) with a Neutral and lowers the price target from $52 to $41.
Vertical Research Downgrades Paramount Global to Mixed
Vertical Research downgrades Paramount Global (NASDAQ:PARA) from Positive to Mixed.
Needham Initiates Coverage On Definitive Healthcare with Buy Rating, Announces Price Target of $30
Needham analyst Ryan MacDonald initiates coverage on Definitive Healthcare (NASDAQ:DH) with a Buy rating and announces Price Target of $30.
Report of New China Lockdowns on Covid Clusters in Shanghai and Xi’an
-AFP
https://www.france24.com/en/live-news/20220706-fresh-covid-outbreaks-put-millions-under-lockdown-in-china-1
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Immutep Announced Tuesday it was Granted Japanese Patent for IMP761, A First-In-Class Immunosuppressive Antibody Targeting Lag-3
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce the grant of a new patent (number7074341) entitled "Anti- LAG-3 Antibodies" by the Japanese Patent Office.
Oppenheimer Initiates Coverage On Portman Ridge Finance with Perform Rating, Announces Price Target of $26
Oppenheimer analyst Mitchel Penn initiates coverage on Portman Ridge Finance (NASDAQ:PTMN) with a Perform rating and announces Price Target of $26.
Wolfe Research Initiates Coverage On Teleflex with Outperform Rating
Wolfe Research analyst Mike Polark initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating.